Halozyme Therapeutics surges as it raises FY24 guidance, driven by increased revenue projections and a new European patent for its drug delivery platform.
https://frontofficesports.com/buzzer-beater-tnt-is-negotiating-for-4th-nba-rights-package/#:~:text=WBD%20is%20in%20negotiations%20to,regular%2Dseason%20and%20playoff%20games.WBD is in negotiations to secure a possible